Vitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease population

被引:21
|
作者
Ngai, Melissa [1 ]
Lin, Valerie [2 ]
Wong, Hung Chew [3 ]
Vathsala, Anantharaman [3 ,4 ]
How, Priscilla [2 ,4 ]
机构
[1] Natl Univ Singapore Hosp, Dept Pharm, Singapore, Singapore
[2] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117543, Singapore
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117543, Singapore
[4] Natl Univ Singapore Hosp, Dept Med Nephrol, Singapore, Singapore
关键词
vitamin D; chronic kidney disease; 25-hydroxyvitamin D; mineral and bone disorder; prevalence; 25-HYDROXYVITAMIN D; D DEFICIENCY; PREVALENCE; CKD; PTH; PHOSPHORUS; NUTRITION; MORTALITY; CALCIUM; HEALTH;
D O I
10.5414/CN108182
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Vitamin D deficiency is associated with secondary hyperparathyroidism and mineral and bone disorder (MBD) in chronic kidney disease (CKD). This study aimed to determine the prevalence of vitamin D insufficiency/deficiency, and the association between vitamin D status and MBD in a multi-ethnic CKD population in Southeast Asia. Methods: Predialysis CKD patients were included in this cross-sectional study. Patient demographics, medical/medication histories, and laboratory parameters (serum 25-hydroxyvitamin D (25(OH)D), creatinine, phosphate (P), calcium, albumin, and intact-PTH (i-PTH)) were collected and compared among patients with various CKD stages. The association between 25(OH)D and these parameters was determined by multiple linear regression. Results: A total of 196 patients with mean +/- SD eGFR of 26.4 +/- 11.2 mL/min/1.73 m(2) was included. Vitamin D deficiency (25(OH)D concentration < 15 ng/mL) and insufficiency (25(OH)D concentration 16 - 30 ng/mL) was found in 29.1% and 57.7% of the patients, respectively. Mean +/- SD serum 25(OH)D was 20.8 +/- 9.3 ng/mL. Female patients had lower vitamin D concentrations than males (16.9 ng/mL vs. 23.9 ng/mL; p < 0.001). Vitamin D levels were also higher in Chinese (22.3 ng/mL) than Malay (17.3 ng/mL) and Indian (13.1 ng/mL) patients (p < 0.05). Non-adjusted analyses showed higher i-PTH concentration in vitamin D deficient patients (p < 0.05). Conclusion: Despite being a sun-rich country all year round, the majority (86.8%) of predialysis CKD patients in Singapore have suboptimal vitamin D status. Lower vitamin D concentrations were found in females and in those with darker skin tone. Vitamin D deficient patients also tended to have higher i-PTH levels.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 50 条
  • [1] Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines
    Bover, Jordi
    Masso, Elisabet
    Gifre, Laia
    Alfieri, Carlo
    Soler-Majoral, Jordi
    Fusaro, Maria
    Calabia, Jordi
    Rodriguez-Pena, Rosely
    Rodriguez-Chitiva, Nestor
    Lopez-Baez, Victor
    Sanchez-Baya, Maya
    da Silva, Iara
    Aguilar, Armando
    Bustos, Misael C.
    Rodrigues, Natacha
    Chavez-Iniguez, Jonathan S.
    Romero-Gonzalez, Gregorio
    Valdivielso, Jose Manuel
    Molina, Pablo
    Gorriz, Jose L.
    NUTRIENTS, 2023, 15 (07)
  • [2] Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population
    Lim, Cynthia C.
    Teo, Boon Wee
    Ong, Peng Guan
    Cheung, Carol Y.
    Lim, Su Chi
    Chow, Khuan Yew
    Meng, Chan Choon
    Lee, Jeannette
    Tai, E. Shyong
    Wong, Tien Y.
    Sabanayagam, Charumathi
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (08) : 1018 - 1026
  • [3] Implications for Nutrition Practice in the Mineral-Bone Disorder of Chronic Kidney Disease
    Moore, Linda W.
    NUTRITION IN CLINICAL PRACTICE, 2011, 26 (04) : 391 - 400
  • [4] Vitamin D status in children with chronic kidney disease
    Stein, Deborah R.
    Feldman, Henry A.
    Gordon, Catherine M.
    PEDIATRIC NEPHROLOGY, 2012, 27 (08) : 1341 - 1350
  • [5] Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages
    Patel, Sanjeev
    Barron, Jeffrey L.
    Mirzazedeh, Mehdi
    Gallagher, Hugh
    Hyer, Steve
    Cantor, Tom
    Fraser, William D.
    JOURNAL OF BONE AND MINERAL METABOLISM, 2011, 29 (01) : 71 - 79
  • [6] Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder?
    Wesseling-Perry, Katherine
    Salusky, Isidro B.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2009, 18 (04): : 308 - 314
  • [7] Vitamin D metabolites and bone mineral density: The multi-ethnic study of atherosclerosis
    van Ballegooijen, Adriana J.
    Robinson-Cohen, Cassianne
    Katz, Ronit
    Criqui, Michael
    Budoff, Matthew
    Li, Dong
    Siscovick, David
    Hoofnagle, Andy
    Shea, Steven J.
    Burke, Gregory
    de Boer, Ian H.
    Kestenbaum, Bryan
    BONE, 2015, 78 : 186 - 193
  • [8] Pharmacotherapy of chronic kidney disease and mineral bone disorder
    Barreto, Fellype Carvalho
    de Oliveira, Rodrigo Azevedo
    Oliveira, Rodrigo Bueno
    Jorgetti, Vanda
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (17) : 2627 - 2640
  • [9] The current status of chronic kidney disease-mineral and bone disorder management in China
    Zhan, Ya
    He, Xin
    Hong, Daqing
    Wang, Li
    Li, Guisen
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population
    Rojas-Campos, Enrique
    Ruvalcaba-Contreras, Neri
    Campos-Mariz, Alejandro
    Aguilar-Campos, Arantxa
    Andrade-Sierra, Jorge
    Ignacio Cerrillos-Gutierrez, Jose
    Medina-Perez, Miguel
    Evangelista-Carrillo, Luis
    Banda, Adriana
    Cueto-Manzano, Alfonso M.
    ARCHIVES OF MEDICAL RESEARCH, 2024, 55 (04)